Delphia Therapeutics

Series-A
delphiatx.com Biotech & Healthcare Cambridge, United States Founded 2022 11-50
Total Funding $67M
Latest Round $67M Series-A
Last Announced May 2, 2024
Investors 4 Backers
Decision Makers 6 Verified

About Delphia Therapeutics

Delphia is pioneering activation lethality - a next-generation precision medicine approach that targets cancer's surprising vulnerability to oncogene overactivation.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Cambridge, United States
Year Founded 2022
Team Size 11-50
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website delphiatx.com
Domain Registered Date Oct 6, 2022

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised $67,000,000 · Series-A

    fundraisingfox.com

  2. Milestone

    Website domain registered

    delphiatx.com

  3. Milestone

    Company founded

    Cambridge, United States

Investors & Backers

4
Alexandria Venture Investments
GV
Nextech Invest
Polaris

Funding History

1 Round
Series-A · May 2, 2024

Founders & Leadership

3

David Kerstein

CMO

Work email & phone locked Unlock →

Kevin Marks

Founder

Work email & phone locked Unlock →

Reza Mazhari

Chief Business Officer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts